WS #10422

14:43→15:12 UTC

From 499 msgs · 8 key-dev

AbbVie to acquire Apogee Therapeutics for $10.9 billion to expand immunology portfolio; ABBV shares higher.

AbbVie Acquisition of Apogee Therapeutics

AbbVie to acquire Apogee Therapeutics for $10.9 billion to expand immunology portfolio; ABBV shares higher.